Insulin glargine and its place in the treatment of Types 1 and 2 diabetes mellitus

Author： Chatterjee Sudesna   Tringham Jennifer R   Davies Melanie J  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.10, 2006-07, pp. : 1357-1371

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Insulin Glargine: A Review of its Therapeutic Use as a Long-Acting Agent for the Management of Type 1 and 2 Diabetes Mellitus

By McKeage K.   Goa K.L.  

Drugs, Vol. 61, Iss. 11, 2001-01 ,pp. : 1599-1624

Adis International

Access to resources Recommend Favorite

Insulin Glargine: An Updated Review of its Use in the Management of Diabetes Mellitus

By Dunn C.J.   Plosker G.L.   Keating G.M.   McKeage K.   Scott L.J.  

Drugs, Vol. 63, Iss. 16, 2003-01 ,pp. : 1743-1778

Adis International

Access to resources Recommend Favorite

Insulin glargine: advantages in type 1 diabetes mellitus in children and adolescents

By  

Inpharma, Vol. 1, Iss. 1360, 2002-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

Modelling Cost Effectiveness of Insulin Glargine for the Treatment of Type 1 and 2 Diabetes in Canada

By Grima Daniel T.  

PharmacoEconomics, Vol. 25, Iss. 3, 2007-01 ,pp. : 253-266

Adis International

Access to resources Recommend Favorite

Insulin glargine, a sweet choice for diabetes mellitus

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 582, 2009-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite